Precipio, Inc. (PRPO) Dividend History

Precipio, Inc. is a biotechnology company specializing in diagnostic and testing services for cancer and infectious diseases. It develops and offers cutting-edge laboratory techniques, including oncology diagnostics and pathogen testing, aimed at improving patient outcomes through innovative and high-quality testing solutions.

12325 Emmet St, Omaha, NE, 68164
Phone: 203 787 7888
Website:

Dividend History

Precipio, Inc. currently does not pay dividends

Company News

  • Precipio, Inc. (NASDAQ: PRPO), a specialty cancer diagnostics company, reported strong Q1-2025 financial results with 43% year-over-year revenue growth, improved gross margins, and a return to positive operating cash flow expected by Q2 or Q3 of 2025.

    GlobeNewswire Inc.
  • Precipio, Inc., a specialty cancer diagnostics company, will be hosting its Q4 and year-end 2024 corporate update call on March 31st, 2025. The call will include updates on the company's current core businesses.

    GlobeNewswire Inc.
  • Precipio, Inc., a specialty cancer diagnostics company, will be hosting its Q4 and year-end 2024 corporate update call on March 31st, 2025. The call will include updates on the company's current core businesses.

    GlobeNewswire Inc.
  • Precipio, a cancer diagnostics company, announces the repricing of a portion of its employee stock options to retain valuable employees and align their incentives with shareholders. The company believes this move will ultimately create shareholder value.

    GlobeNewswire Inc.
  • New Shareholders Meeting Date: Friday, June 21 at 9 a.m. Eastern Time New Shareholders Meeting Date: Friday, June 21 at 9 a.m. Eastern Time

    GlobeNewswire Inc.
Dividend data last updated 06/07/2025 11:10:11 UTC